Benchmark dose of alcohol consumption for development of hyperuricemia in Japanese male workers: An 8-year cohort study.
To estimate the benchmark dose (BMD) and their 95% lower confidence limits (BMDL) of alcohol consumption as the reference level for the development of hyperuricemia based on the dose-response relationship.



An 8-year prospective cohort study was conducted in 8097 male workers at a Japanese steel company who received annual health check-ups between 2002 and 2009. The endpoints for development of hyperuricemia were defined as a uric acid ≥7 mg/dL or taking any anti-hyperuricemic medication. The dose-response relationship of alcohol consumption was investigated using multivariate-pooled logistic regression analyses adjusted for other potential covariates. We estimated the BMD and BMDL of alcohol consumption for the development of hyperuricemia, using the parameters obtained by pooled logistic regression with a benchmark response (BMR) of 5% or 10%.



Mean observed years per person was 3.86 years. The incidence rate per 1000 person-years was 61.1. The odds ratio calculated for the development of hyperuricemia was 1.29 [95% confidence interval, (1.22-1.36)] with an increase in alcohol consumption per 1 gou/day (1 gou/day = alcohol 22 g/day). The estimated BMDL/BMD with a BMR of 5% was 2.5/2.8 gou/day (54.5/61.8 g/day) and with a BMR of 10% was 4.0/4.6 gou/day (88.9/100.9 g/day).



The present study showed that alcohol consumption of 2.5 gou/day (=ethanol 55 g/day) caused a distinct increase in the risk of hyperuricemia. Valuable information for preventing alcohol-induced hyperuricemia was obtained by a long-term follow-up study of a large cohort.
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Takashi
T
Makinouchi
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kouichi
K
Sakata
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Mitsuhiro
M
Oishi
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kumihiko
K
Tanaka
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kazuhiro
K
Nogawa
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Miyuki
M
Watanabe
Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: suwa@faculty.chiba-u.jp.
Yasushi
Y
Suwazono
D000328:Adult; D000428:Alcohol Drinking / Q000097:blood* / Q000453:epidemiology* / Q000639:trends; D019985:Benchmarking / Q000379:methods* / Q000639:trends; D015331:Cohort Studies; D005500:Follow-Up Studies; D006801:Humans; D033461:Hyperuricemia / Q000097:blood* / Q000453:epidemiology*; D007564:Japan / Q000453:epidemiology; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009786:Occupational Health Services / Q000379:methods* / Q000639:trends; D011446:Prospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013997:Time Factors
Alcohol consumption; Benchmark dose; Cohort study; Hyperuricemia